News | News By Subject | News by Disease News By Date | Search News

 News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Biogen (BIIB) Gained $1 Billion Overnight After Becoming Goldman Sachs' Favorite Biotech     8/17/2017
Galapagos (GLPG.BR)' Phase II Results With GLPG1690 are 'Extremely Exciting'     8/14/2017
MyoKardia Shares Surge on Positive Phase II Results for Heart Muscle Disease     8/8/2017
Esperion (ESPR) Stock Gains On Strong Phase II Data     8/8/2017
Gemphire Shares Drop on Disappointing Phase II Results for LDL Drug     8/7/2017
Benitec (BLT.AX) Regroups under Partnership with Patrick Soon-Shiong     8/2/2017
Geron (GERN) Under Pressure as Clinical Trial Changes Causes Delays     8/2/2017
Eli Lilly (LLY) Shakes Up Cancer R&D Strategy, Seeks New Home for Seven Pipeline Drugs     7/26/2017
BioPharm Executive: And So It Continues: Let's Get Rid of Clinical Trials (Part 2)     7/26/2017
2 Tiny Cancer Biotechs That Could Gain Steam by Year-End     7/26/2017
5 Biotechs With $45 Billion Worth of Not-Yet Approved Drugs in the Pipeline     7/25/2017
10 Biotechs Tackling Senator John McCain's Form of Aggressive Brain Cancer     7/24/2017
Vertex (VRTX) Gains $8 Billion Overnight as Cystic Fibrosis Combo Drug Wows in Trials     7/21/2017
Kite Pharma (KITE) Touts Remissions Up to 56+ Months in Non-Hodgkin Lymphoma Patients on CAR T-Cell Therapy     7/21/2017
Uncertainty Hits as Roche (RHHBY) is Dealt Multiple Clinical Trial Setbacks     7/21/2017

Featured Stories
Zynerba (ZYNE)’s Failed Cannabidiol Gel Trial Has Upside for Rival GW Pharma (GWPH)     8/8/2017
Roche (RHHBY)’s Tecentriq Hits Trouble with NICE in Bladder Cancer     8/3/2017
Amgen (AMGN) Falls After Earnings Update Reveals Embarassingly 'Bare' Pipeline     7/27/2017
Data Put A Dent In Ironwood (IRWD)'s Expansion Plans     7/24/2017
Genentech (RHHBY) R&D Exec Reveals Alzheimer's is Still A Priority     7/19/2017
In Alzheimer's, The 'Juggernaut Is Changing Course,' Says TauRx Pharma Chief Exec     7/18/2017
Why Biogen (BIIB) Spinoff Bioverativ (BIVV)'s Anemia Drug Could Be A Blockbuster     7/11/2017
Bionomics Limited (BNO.AX): A Company With Deals On The Horizon     7/5/2017
Omeros (OMER): Next Big Thing In Biotech     7/5/2017
Can Merck & Co. (MRK) And Novartis AG (NVS)'s Surprise Heart Drug Success Translate To Blockbuster Sales?     6/29/2017
Will AbbVie (ABBV) Outsmart Biosimilars, And Can Clovis Oncology (CLVS) Win The PARP Race?     6/27/2017
Why This Small Biotech With A Single Drug In Human Trials Might Be A Big Winner     6/22/2017
Vanda (VNDA): Several Catalysts Coming Up     6/21/2017
While Amgen (AMGN)-Size Biotechs Run Into Trouble, These Are The Biotechs With The Most Promising Pipelines     6/19/2017
How This Small Washington Biotech Stands To Outperform Rivals Amgen (AMGN), Eli Lilly (LLY) And Teva (TEVA) In Migraine Drugs     6/9/2017
Medivir (MVRBF) Initiates Clinical Study Of Birinapant In Combination With KEYTRUDA (Pembrolizumab) In Patients With Treatment-Refractory Solid Tumours     8/18/2017
Immunicum Completes Strategic Analysis And Defines Updated Clinical Development Plan For Ilixadencel     8/17/2017
Tempus Selected As Sequencing And Analytics Provider By The Prostate Cancer Clinical Trials Consortium For Phase II Clinical Trial     8/17/2017
Mateon Therapeutics (MATN) Announces Results From Second Interim Analysis Of CA4P Phase II/III FOCUS Study In Platinum-Resistant Ovarian Cancer     8/16/2017
Opthea Presents Additional Positive Data From OPT-302 Phase I/IIa Wet AMD Trial At ASRS Meeting     8/16/2017
ARCA biopharma Announces Completion Of Enrollment For GENETIC-AF Phase IIb Clinical Trial     8/16/2017
Iovance Biotherapeutics Announces First Patient Dosed In C-145-04 Phase II Trial In Cervical Cancer     8/16/2017
New ThromboGenics NV (TBGNF)' Ocriplasmin Clinical And Health Economic Data Presented At ASRS 2017 Annual Scientific Meeting In Boston     8/16/2017
Abeona Therapeutics Announces Pivotal Expansion Of ABO-102 Gene Therapy Clinical Trials In Sanfilippo Syndrome Type A     8/16/2017
U.S. FDA Grants Lion TCR Two Orphan Drug Designations Of T Cell Therapy Against Hepatocellular Carcinoma     8/16/2017
PolyPid Ltd. Completes Enrollment In Phase Ib/II Study Of D-PLEX In Post-Cardiac Surgery Sternal Infection     8/16/2017
Dimerix Limited To Present Analysis Of DMX-200 Phase IIa Clinical Trial In Chronic Kidney Disease At The American Society of Nephrology (ASN) Annual Kidney Week 2017     8/16/2017
Omeros (OMER) Data Show Continued Improvement In Patients With IgA Nephropathy Treated With OMS721     8/15/2017
CymaBay Therapeutics Announces The Publication Of The Seladelpar Proof-Of-Concept Study For Primary Biliary Cholangitis In Lancet Gastroenterology And Hepatology     8/15/2017
Conatus Pharma Announces Completion Of Enrollment In ENCORE-NF Phase IIb Clinical Trial Of Emricasan In Patients With NASH Fibrosis     8/15/2017

More News
No News Posted on that date

Career Tips
The Need for Speed in Today's Biotech Job Search and What This New Rush Means For You     8/17/2017
33 Company-Related Questions to Ask at a Large Pharmaceutical Job Interview     8/17/2017
CRO vs. Big Pharma: Which is the Better Place to Work?     8/7/2017
According to Real Scientists, This is How You Get a Job in Biopharma     8/4/2017
Top 10 Biotech Employers in Massachusetts by Job Listings     8/3/2017
Why Scientists Should Ditch The Postdoc And Just Jump Into The Industry     8/2/2017
How Scientists Can Negotiate Higher Salary Contracts     8/2/2017
The Leadership Skill Everybody Needs-And 90% Of Managers Lack     8/2/2017
This Cover Letter Checklist Can Help You Show Off Your Personality The Right Way     8/2/2017
How Long Will A Successful Career Change To Pharma Manufacturing Take?     8/2/2017
11 Life Science Skills You'll Need in 2020     7/21/2017
Can This Region Become the Country’s Next Big Biotech Hub for Jobs?     7/21/2017
Most Common Mistake Scientists Make When Applying for a Job     7/21/2017
How To Advance Your Scientific Career By Working For A CRO     7/20/2017
How A Scientist With A PhD Is An Advantage At A Job Interview     7/20/2017

Other News Sources
//-->